Allergy battle could be won in five years, says scientist

July 12, 2006

Researchers, working with colleagues at St George's, University of London, are developing drugs designed to stop allergens from entering the body, so rendering them harmless.

Professor David Garrod said the research - recently shortlisted for the Northwest Regional Development Agency's Bionow Project of the Year - takes a completely new approach to the treatment and prevention of allergies.

"The technology is based on our earlier discovery of how allergens, the substances that cause allergy, enter the body through the surface layer of cells that protect the skin and the tubes of the lungs," he said.

"Allergens from pollen or house dust mites are inhaled and then dissolve the binding material between the cells that form these protective linings; they can then enter the body by passing between the cells to cause an allergic response.

"The drugs we are developing -- called Allergen Delivery Inhibitors (ADIs) - are designed to disable these allergens so they can no longer eat through the protective cell layer and block the allergic reaction before it occurs.

"The effect will be like avoiding allergens altogether. Removing carpets and rigorous cleaning of homes are established ways to avoid allergens, but they are only partially effective because their effects do not 'travel' with allergy sufferers.

"ADIs promise to be significantly better because taking a medicine is easier than rigorous housework and pills are portable."

Professor Garrod, who is based within Manchester's Faculty of Life Sciences, said work on the first ADI chemical was well advanced and potential drugs could enter clinical trials as early as 2010.

If successful, the drug would treat established symptoms already found in adult sufferers and, in due course, could be used to prevent allergies in children.

"Prevention of allergies has never before been possible," said Professor Garrod. "Current medicines don't act against the allergen at this early stage - they only ease the symptoms - so the development of these ADIs would be a major breakthrough in our fight against allergies."
-end-
The study has already received nearly £450,000 from the Wellcome Trust but up to £3 million will be needed to develop the drugs to the clinical-trials stage.

Professor Garrod is now seeking investment to take the research to the next stage of development and a potential $26 billion* market.

Notes for editors:

* The estimated $26 billion market for allergen-prevention drugs is supplied by DataMonitor.


Professor David Garrod's collaborative partner at St George's, University London, is Dr Clive Robinson, Reader in respiratory cell science.

University of Manchester

Related Allergies Articles from Brightsurf:

With or without allergies, outcomes similar for hospitalized patients with COVID-19
A new study being presented at this year's virtual American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting examines hospital data to determine if those with allergic conditions had more severe COVID-related disease than those without.

Links between parents' and children's asthma and allergies
New research published in Clinical & Experimental Allergy found that, compared with a father's traits related to allergies and asthma, a mother's traits create a higher risk that a child will develop these same traits in early childhood.

New insight into allergies could improve diagnosis and treatment
A study led by investigators at Massachusetts General Hospital point to a potential marker of these conditions and a new therapeutic strategy.

Got seasonal allergies? Beetles could help
Allergies caused by the common ragweed, Ambrosia artemisiifolia, impact millions, and in Europe alone, around 13.5 million people suffer with symptoms, resulting in 7.4 billion Euros worth of health costs per year, according to the research.

Drinking green tea may help with food allergies
Drinking green tea increases Flavonifractor plautii in the gut, which in turn suppresses an allergic food immune response.

Breastfeeding and risks of allergies and asthma
In an Acta Paediatrica study, exclusive breastfeeding for the first 3 months was linked with a lower risk of respiratory allergies and asthma when children reached 6 years of age.

Search for the source of antibodies would help treat allergies
Researchers of Sechenov University together with their colleagues from Russia and Austria summarised everything known about cells producing group E antibodies.

Changes in onset of spring linked to more allergies across the US
Human-induced climate change is disrupting nature's calendar, including when plants bloom and the spring season starts, and new research from the University of School of Public Health suggests we're increasingly paying the price for it in the form of seasonal allergies.

Prenatal allergies prompt sexual changes in offspring
A single allergic reaction during pregnancy prompts sexual-development changes in the brains of offspring that last a lifetime, new research suggests.

Food allergies: A research update
Families impacted by food allergies will need psychosocial support as they try promising new therapies that enable them to ingest a food allergen daily or wear a patch that administers a controlled dose of that food allergen.

Read More: Allergies News and Allergies Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.